72 related articles for article (PubMed ID: 20974518)
21. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I; Tillman DM; Houghton JA
Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
[TBL] [Abstract][Full Text] [Related]
22. p53 stabilization can be uncoupled from its role in transcriptional activation by loss of PTTG1/securin.
Bernal JA; Hernández A
J Biochem; 2007 May; 141(5):737-45. PubMed ID: 17383977
[TBL] [Abstract][Full Text] [Related]
23. APTM, a Thiophene Heterocyclic Compound, Inhibits Human Colon Cancer HCT116 Cell Proliferation Through p53-Dependent Induction of Apoptosis.
Liao X; Huang J; Lin W; Long Z; Xie Y; Ma W
DNA Cell Biol; 2018 Feb; 37(2):70-77. PubMed ID: 29215922
[TBL] [Abstract][Full Text] [Related]
24. Combining fisetin and ionizing radiation suppresses the growth of mammalian colorectal cancers in xenograft tumor models.
Leu JD; Wang BS; Chiu SJ; Chang CY; Chen CC; Chen FD; Avirmed S; Lee YJ
Oncol Lett; 2016 Dec; 12(6):4975-4982. PubMed ID: 28105204
[TBL] [Abstract][Full Text] [Related]
25. Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives.
Brito H; Martins AC; Lavrado J; Mendes E; Francisco AP; Santos SA; Ohnmacht SA; Kim NS; Rodrigues CM; Moreira R; Neidle S; Borralho PM; Paulo A
PLoS One; 2015; 10(5):e0126891. PubMed ID: 26024321
[TBL] [Abstract][Full Text] [Related]
26. Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells.
Chen HY; Islam A; Yuan TM; Chen SW; Liu PF; Chueh PJ
J Exp Clin Cancer Res; 2018 Jul; 37(1):161. PubMed ID: 30029680
[TBL] [Abstract][Full Text] [Related]
27. Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation.
Chan JY; Tan BK; Lee SC
Anticancer Res; 2009 Aug; 29(8):3043-7. PubMed ID: 19661313
[TBL] [Abstract][Full Text] [Related]
28. Activation of p53 with ilimaquinone and ethylsmenoquinone, marine sponge metabolites, induces apoptosis and autophagy in colon cancer cells.
Lee HY; Chung KJ; Hwang IH; Gwak J; Park S; Ju BG; Yun E; Kim DE; Chung YH; Na M; Song GY; Oh S
Mar Drugs; 2015 Jan; 13(1):543-57. PubMed ID: 25603347
[TBL] [Abstract][Full Text] [Related]
29. Luteolin Induces Apoptosis and Autophagy in HCT116 Colon Cancer Cells via p53-Dependent Pathway.
Yoo HS; Won SB; Kwon YH
Nutr Cancer; 2022; 74(2):677-686. PubMed ID: 33757400
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effect of 1, 8-cineole against colon cancer.
Murata S; Shiragami R; Kosugi C; Tezuka T; Yamazaki M; Hirano A; Yoshimura Y; Suzuki M; Shuto K; Ohkohchi N; Koda K
Oncol Rep; 2013 Dec; 30(6):2647-52. PubMed ID: 24085263
[TBL] [Abstract][Full Text] [Related]
31. Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells.
Tseng HH; Chuah QY; Yang PM; Chen CT; Chao JC; Lin MD; Chiu SJ
PLoS One; 2012; 7(4):e36006. PubMed ID: 22563433
[TBL] [Abstract][Full Text] [Related]
32. The depletion of securin enhances butein-induced apoptosis and tumor inhibition in human colorectal cancer.
Huang YT; Lin CI; Chien PH; Tang TT; Lin J; Chao JI
Chem Biol Interact; 2014 Sep; 220():41-50. PubMed ID: 24931875
[TBL] [Abstract][Full Text] [Related]
33. Depletion of the thiol oxidoreductase ERp57 in tumor cells inhibits proliferation and increases sensitivity to ionizing radiation and chemotherapeutics.
Hussmann M; Janke K; Kranz P; Neumann F; Mersch E; Baumann M; Goepelt K; Brockmeier U; Metzen E
Oncotarget; 2015 Nov; 6(36):39247-61. PubMed ID: 26513173
[TBL] [Abstract][Full Text] [Related]
34. Opposite expression of securin and γ-H2AX regulates baicalein-induced cancer cell death.
Jiang RH; Su WC; Liu HF; Huang HS; Chao JI
J Cell Biochem; 2010 Oct; 111(2):274-83. PubMed ID: 20506293
[TBL] [Abstract][Full Text] [Related]
35. Urolithin A gains in antiproliferative capacity by reducing the glycolytic potential via the p53/TIGAR axis in colon cancer cells.
Norden E; Heiss EH
Carcinogenesis; 2019 Mar; 40(1):93-101. PubMed ID: 30418550
[TBL] [Abstract][Full Text] [Related]
36. Fisetin: An anticancer perspective.
Imran M; Saeed F; Gilani SA; Shariati MA; Imran A; Afzaal M; Atif M; Tufail T; Anjum FM
Food Sci Nutr; 2021 Jan; 9(1):3-16. PubMed ID: 33473265
[TBL] [Abstract][Full Text] [Related]
37. Human full-length Securin is a natively unfolded protein.
Sánchez-Puig N; Veprintsev DB; Fersht AR
Protein Sci; 2005 Jun; 14(6):1410-8. PubMed ID: 15929994
[TBL] [Abstract][Full Text] [Related]
38. Fisetin nanoparticles based on cells cycle and apoptosis intervention for the treatment of lymphoma and leukemia.
Yang T; Gou H; Lin T; Yang Y; Jin X; Dong T; Zhang Y; Chen X
Int J Pharm; 2024 Apr; 654():123971. PubMed ID: 38452832
[TBL] [Abstract][Full Text] [Related]
39. Induction of sestrin 2 is associated with fisetin-mediated apoptosis in human head and neck cancer cell lines.
Won DH; Chung SH; Shin JA; Hong KO; Yang IH; Yun JW; Cho SD
J Clin Biochem Nutr; 2019 Mar; 64(2):97-105. PubMed ID: 30936621
[TBL] [Abstract][Full Text] [Related]
40. Over-expression of wild-type Securin leads to aneuploidy in human cells.
Christopoulou L; Moore JD; Tyler-Smith C
Cancer Lett; 2003 Dec; 202(2):213-8. PubMed ID: 14643451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
